Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Coghill

Showing results (211-220 of 230) with videos related to

Pageof 23
Sort By:
JCPP Advances|July 11, 2023
A national harmonised data collection network for neurodevelopmental disorders: A transdiagnostic assessment protocol for neurodevelopment, mental health, functioning and well-beingKelsie A Boulton, David Coghill, Natalie Silove, et al.
Molecular Autism|August 6, 2021
The Monash Autism-ADHD genetics and neurodevelopment (MAGNET) project design and methodologies: a dimensional approach to understanding neurobiological and genetic aetiologyRachael Knott, Beth P Johnson, Jeggan Tiego, et al.
Journal of Attention Disorders|February 17, 2024
The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) ProjectSara Carucci, Alessandro Zuddas, Angelico Lampis, et al.
JAMA Psychiatry|July 27, 2017
Association of Risk of Suicide Attempts With Methylphenidate TreatmentKenneth K C Man, David Coghill, Esther W Chan, et al.
Annals of Clinical and Translational Neurology|December 5, 2019
Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1Jonathan M Payne, Stephen J C Hearps, Karin S Walsh, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|October 31, 2017
Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorderDavid Daley, Saskia Van Der Oord, Maite Ferrin, et al.
Neuroscience and Biobehavioral Reviews|September 24, 2019
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidenceHelga Krinzinger, Charlotte L Hall, Madeleine J Groom, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2026
Child and adolescent psychiatry: challenges, solutions, opportunities, and future directionsSamuele Cortese, Celso Arango, Claudia Aymerich, et al.
Neuroscience and Biobehavioral Reviews|March 31, 2023
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indicationsSamuele Cortese, Katherine McGinn, Mikkel Højlund, et al.
Nature Medicine|April 8, 2024
Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother-child pairsAdrienne Y L Chan, Le Gao, Miyuki Hsing-Chun Hsieh, et al.
Pageof 23

Showing results (211-220 of 230) with videos related to

Sort By:
Pageof 23
JCPP Advances|July 11, 2023
A national harmonised data collection network for neurodevelopmental disorders: A transdiagnostic assessment protocol for neurodevelopment, mental health, functioning and well-beingKelsie A Boulton, David Coghill, Natalie Silove, et al.
Molecular Autism|August 6, 2021
The Monash Autism-ADHD genetics and neurodevelopment (MAGNET) project design and methodologies: a dimensional approach to understanding neurobiological and genetic aetiologyRachael Knott, Beth P Johnson, Jeggan Tiego, et al.
Journal of Attention Disorders|February 17, 2024
The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) ProjectSara Carucci, Alessandro Zuddas, Angelico Lampis, et al.
JAMA Psychiatry|July 27, 2017
Association of Risk of Suicide Attempts With Methylphenidate TreatmentKenneth K C Man, David Coghill, Esther W Chan, et al.
Annals of Clinical and Translational Neurology|December 5, 2019
Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1Jonathan M Payne, Stephen J C Hearps, Karin S Walsh, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|October 31, 2017
Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorderDavid Daley, Saskia Van Der Oord, Maite Ferrin, et al.
Neuroscience and Biobehavioral Reviews|September 24, 2019
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidenceHelga Krinzinger, Charlotte L Hall, Madeleine J Groom, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2026
Child and adolescent psychiatry: challenges, solutions, opportunities, and future directionsSamuele Cortese, Celso Arango, Claudia Aymerich, et al.
Neuroscience and Biobehavioral Reviews|March 31, 2023
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indicationsSamuele Cortese, Katherine McGinn, Mikkel Højlund, et al.
Nature Medicine|April 8, 2024
Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother-child pairsAdrienne Y L Chan, Le Gao, Miyuki Hsing-Chun Hsieh, et al.
Pageof 23